When less is more: dual antiplatelet therapy in elective percutaneous coronary intervention

Comment on ‘Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial’, which was presented at the 2020 Scientific Sessions of the American Heart Association and published in The Lancet (doi.org/10.1016/S0140-6736(20)32236-4).
Source: European Heart Journal - Category: Cardiology Source Type: research